US 11813267
DNA-PK inhibitors
granted A61KA61K31/506A61K31/5377
Quick answer
US patent 11813267 (DNA-PK inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/506, A61K31/5377, A61K31/5386, A61P